Memorial Sloan Kettering Cancer Center (MSKCC) — New York, New York

Memorial Sloan Kettering Cancer Center (MSKCC) is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center (MSKCC) has participated in 13 clinical trials with 5 currently active.

Therapeutic areas: Triple Negative Breast Cancer, Metastatic Cancer, Epithelial Tumor.

Sponsors: Ayala Pharmaceuticals, Inc,, Akamis Bio, Caribou Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center (MSKCC)?

Memorial Sloan Kettering Cancer Center (MSKCC) has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center (MSKCC) conducted?

Memorial Sloan Kettering Cancer Center (MSKCC) has 13 clinical trials on record, with 5 currently active. Their work covers Triple Negative Breast Cancer, Metastatic Cancer, Epithelial Tumor.

Is Memorial Sloan Kettering Cancer Center (MSKCC) accredited by Crixeo Health?

Yes — Memorial Sloan Kettering Cancer Center (MSKCC) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center (MSKCC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.